•
Dec 31, 2024
Option Care Health Q4 2024 Earnings Report
Option Care Health reported strong revenue and income growth in Q4 2024.
Key Takeaways
Option Care Health delivered solid financial results in Q4 2024 with net revenue growth of 19.7%, increased net income, and a higher adjusted EBITDA, demonstrating resilience in a dynamic market environment.
Net revenue increased by 19.7% to $1.35 billion.
Net income rose to $60.1 million, up from $57.2 million in Q4 2023.
Adjusted EBITDA grew by 8.9% to $121.6 million.
Adjusted diluted EPS increased by 15.8% to $0.44.
Option Care Health
Option Care Health
Forward Guidance
Option Care Health expects revenue growth, strong adjusted EBITDA, and continued operational resilience in FY 2025.
Positive Outlook
- Expected net revenue of $5.3 billion to $5.5 billion.
- Adjusted EBITDA projected between $450 million and $470 million.
- Adjusted diluted EPS anticipated between $1.59 and $1.69.
- Cash flow from operations forecasted at $320 million or more.
- Anticipated effective tax rate of 25%-27%.
Challenges Ahead
- Ongoing inflationary pressures.
- Potential interest expense increase.
- Market uncertainties.
- Impact of non-operating income.
- Competitive pressures in the healthcare industry.